If we want to avoid another Martin Shkreli or an EpiPen pricing fiasco, this is how we need to deal with … – The Independent


The Independent

If we want to avoid another Martin Shkreli or an EpiPen pricing fiasco, this is how we need to deal with
The Independent
Many will say that responsibility lies with the greedy bosses of these companies. Since an outfit called Mylan acquired the “EpiPen” in 2007 the price of the emergency allergy treatment has risen almost five fold. Over that period Mylan’s boss, Heather

and more »